Ajax-Loading

Eli Lilly and Company - Debt To Capital Ratio

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in Percent.

The item "Debt-To-Capital-Ratio" stands at 64.11 percent as of 09/30/2025, the lowest value since 09/30/2023.

As of the end of Eli Lilly and Company's third quarter, the item "Debt To Capital Ratio" stands at 64.11 Percent. This represents a decrease of -4.48 percentage points compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -4.49 percentage points compared to the value the year prior.
The 1 year change in percentage points is -4.49.
The 3 year change in percentage points is 2.91.

The Serie's long term average value is 65.98 percent. It's latest available value, on 09/30/2025, is 1.87 percentage points lower, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is +3.72.
The Serie's change in percentage points from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -6.84.

Debt To Capital Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Debt To Capital Ratio486,508,953,600.00
LogoAbbVie Inc - Debt To Capital Ratio399,570,305,024.00
LogoRoche Holding AG - Debt To Capital Ratio317,433,206,677.55
LogoAstraZeneca PLC - Debt To Capital Ratio280,205,508,085.11
LogoNovartis AG - Debt To Capital Ratio255,096,620,580.91